| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 1.98e-09 | 33 | 73 | 6 | GO:0005217 | |
| GeneOntologyMolecularFunction | intracellularly cAMP-activated cation channel activity | 3.39e-08 | 10 | 73 | 4 | GO:0005222 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 8.29e-08 | 152 | 73 | 8 | GO:0022843 | |
| GeneOntologyMolecularFunction | intracellularly cyclic nucleotide-activated monoatomic cation channel activity | 1.15e-07 | 13 | 73 | 4 | GO:0005221 | |
| GeneOntologyMolecularFunction | cyclic nucleotide-activated monoatomic ion channel activity | 1.15e-07 | 13 | 73 | 4 | GO:0043855 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.31e-07 | 182 | 73 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.60e-07 | 184 | 73 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | cAMP binding | 1.96e-06 | 25 | 73 | 4 | GO:0030552 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.31e-06 | 26 | 73 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | cyclic nucleotide binding | 1.23e-05 | 39 | 73 | 4 | GO:0030551 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.23e-05 | 140 | 73 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 2.39e-05 | 46 | 73 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.94e-05 | 334 | 73 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.56e-05 | 343 | 73 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.90e-05 | 52 | 73 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 4.83e-05 | 465 | 73 | 9 | GO:0046873 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 7.50e-05 | 193 | 73 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | FZD3 GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 OR6C68 OR2A5 CCR7 OR5AR1 PTGFR | 8.01e-05 | 884 | 73 | 12 | GO:0004930 |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 8.40e-05 | 197 | 73 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 HCN2 RYR1 ATP6V0A2 SLC5A4 | 9.07e-05 | 627 | 73 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 TRPA1 FZD3 GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 CD79B OR6C68 OR2A5 CCR7 OR5AR1 PTGFR | 9.38e-05 | 1353 | 73 | 15 | GO:0004888 |
| GeneOntologyMolecularFunction | sterol binding | 1.33e-04 | 71 | 73 | 4 | GO:0032934 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 HCN2 RYR1 ATP6V0A2 SLC5A4 | 1.45e-04 | 664 | 73 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 2.67e-04 | 459 | 73 | 8 | GO:0005216 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 4.08e-04 | 171 | 73 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 HCN2 RYR1 ATP6V0A2 SLC5A4 | 4.19e-04 | 758 | 73 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 5.33e-04 | 102 | 73 | 4 | GO:0005249 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 HCN2 RYR1 ATP6V0A2 SLC5A4 | 5.95e-04 | 793 | 73 | 10 | GO:0015075 |
| GeneOntologyMolecularFunction | channel activity | 6.50e-04 | 525 | 73 | 8 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 6.58e-04 | 526 | 73 | 8 | GO:0022803 | |
| GeneOntologyMolecularFunction | transporter activity | NPC1 CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 OSBPL10 HCN2 STAR RYR1 ATP6V0A2 SLC5A4 | 7.26e-04 | 1289 | 73 | 13 | GO:0005215 |
| GeneOntologyMolecularFunction | olfactory receptor activity | 9.94e-04 | 431 | 73 | 7 | GO:0004984 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.17e-03 | 14 | 73 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | potassium channel activity | 1.25e-03 | 128 | 73 | 4 | GO:0005267 | |
| GeneOntologyMolecularFunction | cholesterol binding | 1.25e-03 | 58 | 73 | 3 | GO:0015485 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.28e-03 | 129 | 73 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | steroid binding | 1.44e-03 | 133 | 73 | 4 | GO:0005496 | |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.73e-03 | 17 | 73 | 2 | GO:0046703 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.94e-03 | 18 | 73 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.28e-03 | 151 | 73 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 3.28e-03 | 167 | 73 | 4 | GO:0015079 | |
| GeneOntologyMolecularFunction | virus receptor activity | 3.74e-03 | 85 | 73 | 3 | GO:0001618 | |
| GeneOntologyMolecularFunction | exogenous protein binding | 3.86e-03 | 86 | 73 | 3 | GO:0140272 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 5.72e-03 | 31 | 73 | 2 | GO:0099604 | |
| GeneOntologyMolecularFunction | alcohol binding | 6.21e-03 | 102 | 73 | 3 | GO:0043178 | |
| GeneOntologyMolecularFunction | chemokine binding | 6.47e-03 | 33 | 73 | 2 | GO:0019956 | |
| GeneOntologyMolecularFunction | hormone receptor binding | 6.86e-03 | 34 | 73 | 2 | GO:0051427 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | NPC1 CACNA1B CACNA1C TRPA1 HCN4 MTOR GLDC HCN1 HCN3 ULBP2 RAET1L TAF2 GNAS HCN2 PTGFR TOP2B RYR1 | 8.46e-08 | 1048 | 72 | 17 | GO:0014070 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | NPC1 JAK3 CACNA1B HCN4 MTOR GLDC HCN1 HCN3 ULBP2 RAET1L CCR7 GNAS HCN2 RNF139 ITGB3 TOP2B RYR1 | 1.29e-06 | 1272 | 72 | 17 | GO:1901698 |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 2.30e-06 | 61 | 72 | 5 | GO:0003254 | |
| GeneOntologyBiologicalProcess | T-helper 1 cell differentiation | 3.03e-06 | 29 | 72 | 4 | GO:0045063 | |
| GeneOntologyBiologicalProcess | response to organophosphorus | 1.03e-05 | 142 | 72 | 6 | GO:0046683 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | JAK3 HCN4 MTOR HCN1 HCN3 ULBP2 RAET1L GNAS HCN2 ITGB3 TOP2B RYR1 | 1.04e-05 | 752 | 72 | 12 | GO:1901699 |
| GeneOntologyBiologicalProcess | regulation of T-helper 1 cell differentiation | 1.44e-05 | 14 | 72 | 3 | GO:0045625 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 2.50e-05 | 166 | 72 | 6 | GO:0014074 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 3.51e-05 | 53 | 72 | 4 | GO:0071320 | |
| GeneOntologyBiologicalProcess | metal ion transport | JAK3 CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 CCR7 GNAS HCN2 ITGB3 RYR1 SLC5A4 | 3.74e-05 | 1000 | 72 | 13 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | JAK3 CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 CCR7 GNAS HCN2 ITGB3 RYR1 ATP6V0A2 SLC5A4 | 3.97e-05 | 1157 | 72 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B CACNA1C TRPA1 HCN4 MTOR HCN1 HCN3 CCR7 HCN2 ITGB3 RYR1 ATP6V0A2 SLC5A4 | 4.45e-05 | 1017 | 72 | 13 | GO:0098660 |
| GeneOntologyBiologicalProcess | cellular response to organic cyclic compound | 4.57e-05 | 605 | 72 | 10 | GO:0071407 | |
| GeneOntologyBiologicalProcess | T-helper 1 type immune response | 5.02e-05 | 58 | 72 | 4 | GO:0042088 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 6.54e-05 | 121 | 72 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | JAK3 CACNA1B CACNA1C TRPA1 HCN4 MTOR HCN1 HCN3 CCR7 GNAS HCN2 ITGB3 RYR1 ATP6V0A2 SLC5A4 | 6.56e-05 | 1374 | 72 | 15 | GO:0006811 |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 6.87e-05 | 23 | 72 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | action potential | 7.27e-05 | 201 | 72 | 6 | GO:0001508 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 CCR7 HCN2 ITGB3 RYR1 ATP6V0A2 SLC5A4 | 7.66e-05 | 922 | 72 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B CACNA1C TRPA1 HCN4 HCN1 HCN3 CCR7 HCN2 ITGB3 RYR1 ATP6V0A2 SLC5A4 | 9.39e-05 | 942 | 72 | 12 | GO:0098655 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 1.11e-04 | 217 | 72 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B CACNA1C TRPA1 HCN4 MTOR HCN1 HCN3 CCR7 HCN2 ITGB3 RYR1 ATP6V0A2 SLC5A4 | 1.13e-04 | 1115 | 72 | 13 | GO:0034220 |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 1.17e-04 | 547 | 72 | 9 | GO:0007606 | |
| GeneOntologyBiologicalProcess | cellular response to oxygen-containing compound | JAK3 TRPA1 HCN4 MTOR CD80 HCN1 HCN3 ULBP2 RAET1L GNAS HCN2 PTGFR ITGB3 TOP2B RYR1 | 1.20e-04 | 1450 | 72 | 15 | GO:1901701 |
| GeneOntologyBiologicalProcess | regulation of action potential | 1.85e-04 | 81 | 72 | 4 | GO:0098900 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 2.13e-04 | 465 | 72 | 8 | GO:0007608 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell apoptotic process | 2.33e-04 | 86 | 72 | 4 | GO:1904036 | |
| GeneOntologyBiologicalProcess | negative regulation of macroautophagy | 2.46e-04 | 35 | 72 | 3 | GO:0016242 | |
| GeneOntologyBiologicalProcess | regulation of T-helper 1 type immune response | 2.46e-04 | 35 | 72 | 3 | GO:0002825 | |
| GeneOntologyBiologicalProcess | cellular response to cGMP | 2.50e-04 | 7 | 72 | 2 | GO:0071321 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 2.68e-04 | 36 | 72 | 3 | GO:0034694 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.68e-04 | 36 | 72 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 2.82e-04 | 485 | 72 | 8 | GO:0050907 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | FZD3 GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 OR6C68 OR2A5 CCR7 GNAS OR5AR1 PTGFR ITGB3 | 2.88e-04 | 1395 | 72 | 14 | GO:0007186 |
| GeneOntologyBiologicalProcess | T-helper cell differentiation | 3.02e-04 | 92 | 72 | 4 | GO:0042093 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation involved in immune response | 3.28e-04 | 94 | 72 | 4 | GO:0002294 | |
| GeneOntologyBiologicalProcess | regulation of cholangiocyte proliferation | 3.32e-04 | 8 | 72 | 2 | GO:1904054 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation involved in immune response | 3.42e-04 | 95 | 72 | 4 | GO:0002293 | |
| GeneOntologyBiologicalProcess | response to cAMP | 3.70e-04 | 97 | 72 | 4 | GO:0051591 | |
| GeneOntologyBiologicalProcess | alpha-beta T cell activation involved in immune response | 3.85e-04 | 98 | 72 | 4 | GO:0002287 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.98e-04 | 275 | 72 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | susceptibility to natural killer cell mediated cytotoxicity | 4.26e-04 | 9 | 72 | 2 | GO:0042271 | |
| GeneOntologyBiologicalProcess | response to cGMP | 4.26e-04 | 9 | 72 | 2 | GO:0070305 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 1 cell differentiation | 4.26e-04 | 9 | 72 | 2 | GO:0045627 | |
| GeneOntologyBiologicalProcess | T cell differentiation involved in immune response | 4.65e-04 | 103 | 72 | 4 | GO:0002292 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | 4.73e-04 | 524 | 72 | 8 | GO:0009593 | |
| GeneOntologyBiologicalProcess | cholangiocyte proliferation | 5.31e-04 | 10 | 72 | 2 | GO:1990705 | |
| GeneOntologyBiologicalProcess | T cell costimulation | 7.53e-04 | 51 | 72 | 3 | GO:0031295 | |
| GeneOntologyBiologicalProcess | response to pain | 7.53e-04 | 51 | 72 | 3 | GO:0048265 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 7.69e-04 | 432 | 72 | 7 | GO:0050911 | |
| GeneOntologyBiologicalProcess | urinary bladder smooth muscle contraction | 7.75e-04 | 12 | 72 | 2 | GO:0014832 | |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell differentiation | 8.01e-04 | 119 | 72 | 4 | GO:0043367 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 8.04e-04 | 208 | 72 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | 8.33e-04 | 438 | 72 | 7 | GO:0032970 | |
| GeneOntologyBiologicalProcess | lymphocyte costimulation | 8.43e-04 | 53 | 72 | 3 | GO:0031294 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | 9.38e-04 | 582 | 72 | 8 | GO:0050906 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 9.91e-04 | 126 | 72 | 4 | GO:0033555 | |
| GeneOntologyBiologicalProcess | regulation of T-helper cell differentiation | 1.04e-03 | 57 | 72 | 3 | GO:0045622 | |
| GeneOntologyBiologicalProcess | regulation of dendritic cell apoptotic process | 1.06e-03 | 14 | 72 | 2 | GO:2000668 | |
| GeneOntologyBiologicalProcess | dendritic cell apoptotic process | 1.06e-03 | 14 | 72 | 2 | GO:0097048 | |
| GeneOntologyBiologicalProcess | urinary tract smooth muscle contraction | 1.23e-03 | 15 | 72 | 2 | GO:0014848 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 1.32e-03 | 614 | 72 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.38e-03 | 235 | 72 | 5 | GO:0002822 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.39e-03 | 63 | 72 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent | 1.40e-03 | 16 | 72 | 2 | GO:0002486 | |
| GeneOntologyCellularComponent | HCN channel complex | 1.37e-10 | 4 | 73 | 4 | GO:0098855 | |
| GeneOntologyCellularComponent | cation channel complex | 1.80e-05 | 235 | 73 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1B CACNA1C HCN4 FZD3 MTOR HCN1 RNF112 HCN3 GNAS HCN2 DMWD STAR | 2.98e-05 | 835 | 73 | 12 | GO:0043025 |
| GeneOntologyCellularComponent | cell body | CACNA1B CACNA1C HCN4 FZD3 MTOR HCN1 RNF112 HCN3 GNAS HCN2 DMWD STAR | 8.33e-05 | 929 | 73 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | dendritic shaft | 1.31e-04 | 74 | 73 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1B CACNA1C COPG1 HCN4 HCN1 HCN3 CD79B GNAS EMC2 HCN2 ERN2 RNF139 ITGB3 RYR1 ATP6V0A2 | 1.75e-04 | 1498 | 73 | 15 | GO:0098796 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 2.91e-04 | 91 | 73 | 4 | GO:0008076 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.50e-04 | 378 | 73 | 7 | GO:0034702 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.85e-04 | 785 | 73 | 10 | GO:0098797 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 4.70e-04 | 523 | 73 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | potassium channel complex | 4.83e-04 | 104 | 73 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 5.57e-04 | 46 | 73 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | transporter complex | 6.54e-04 | 550 | 73 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | dendrite | 7.68e-04 | 858 | 73 | 10 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 7.82e-04 | 860 | 73 | 10 | GO:0097447 | |
| GeneOntologyCellularComponent | side of membrane | 8.93e-04 | 875 | 73 | 10 | GO:0098552 | |
| GeneOntologyCellularComponent | endoplasmic reticulum protein-containing complex | 9.64e-04 | 125 | 73 | 4 | GO:0140534 | |
| GeneOntologyCellularComponent | extrinsic component of cytoplasmic side of plasma membrane | 9.92e-04 | 56 | 73 | 3 | GO:0031234 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1B CACNA1C HCN4 FZD3 MTOR HCN1 RNF112 HCN3 GNAS HCN2 DMWD STAR | 1.05e-03 | 1228 | 73 | 12 | GO:0036477 |
| GeneOntologyCellularComponent | extrinsic component of membrane | 1.26e-03 | 230 | 73 | 5 | GO:0019898 | |
| GeneOntologyCellularComponent | cell surface | CACNA1C FZD3 CD80 HCN1 TSPAN8 PKHD1 ULBP2 CD79B RAET1L CCR7 ITGB3 | 1.56e-03 | 1111 | 73 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | calcium channel complex | 2.13e-03 | 73 | 73 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.21e-03 | 519 | 73 | 7 | GO:0009897 | |
| Domain | Ion_trans_N | 1.92e-10 | 4 | 71 | 4 | PF08412 | |
| Domain | Ion_trans_N | 1.92e-10 | 4 | 71 | 4 | IPR013621 | |
| Domain | Ion_trans_dom | 1.16e-08 | 114 | 71 | 8 | IPR005821 | |
| Domain | Ion_trans | 1.16e-08 | 114 | 71 | 8 | PF00520 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 1.86e-07 | 14 | 71 | 4 | IPR003938 | |
| Domain | CNMP_BINDING_1 | 6.36e-06 | 32 | 71 | 4 | PS00888 | |
| Domain | CNMP_BINDING_2 | 6.36e-06 | 32 | 71 | 4 | PS00889 | |
| Domain | cNMP | 8.16e-06 | 34 | 71 | 4 | SM00100 | |
| Domain | cNMP_binding | 8.16e-06 | 34 | 71 | 4 | PF00027 | |
| Domain | cNMP-bd_dom | 9.18e-06 | 35 | 71 | 4 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 9.18e-06 | 35 | 71 | 4 | PS50042 | |
| Domain | cNMP-bd-like | 1.28e-05 | 38 | 71 | 4 | IPR018490 | |
| Domain | cNMP-bd_CS | 2.85e-05 | 16 | 71 | 3 | IPR018488 | |
| Domain | - | 3.29e-05 | 48 | 71 | 4 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 4.19e-05 | 51 | 71 | 4 | IPR014710 | |
| Domain | GPCR_Rhodpsn_7TM | GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 OR6C68 OR2A5 CCR7 OR5AR1 PTGFR | 4.21e-05 | 670 | 71 | 11 | IPR017452 |
| Domain | 7tm_1 | GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 OR6C68 OR2A5 CCR7 OR5AR1 PTGFR | 4.63e-05 | 677 | 71 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 OR6C68 OR2A5 CCR7 OR5AR1 PTGFR | 5.14e-05 | 685 | 71 | 11 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 OR6C68 OR2A5 CCR7 OR5AR1 PTGFR | 5.56e-05 | 691 | 71 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR142 OR13A1 OR1A1 GPR141 OR6Y1 OR1A2 OR6C68 OR2A5 CCR7 OR5AR1 PTGFR | 5.64e-05 | 692 | 71 | 11 | IPR000276 |
| Domain | PQQ | 2.12e-04 | 6 | 71 | 2 | SM00564 | |
| Domain | PQQ_beta_propeller_repeat | 2.12e-04 | 6 | 71 | 2 | IPR018391 | |
| Domain | - | 2.12e-04 | 6 | 71 | 2 | 2.140.10.10 | |
| Domain | Quinoprotein_ADH-like_fam | 2.12e-04 | 6 | 71 | 2 | IPR027295 | |
| Domain | PQQ_repeat | 2.12e-04 | 6 | 71 | 2 | IPR002372 | |
| Domain | VDCC_a1su_IQ | 2.96e-04 | 7 | 71 | 2 | IPR014873 | |
| Domain | GPHH | 2.96e-04 | 7 | 71 | 2 | PF16905 | |
| Domain | GPHH_dom | 2.96e-04 | 7 | 71 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 2.96e-04 | 7 | 71 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.96e-04 | 7 | 71 | 2 | PF08763 | |
| Domain | VDCCAlpha1 | 6.29e-04 | 10 | 71 | 2 | IPR002077 | |
| Domain | Olfact_rcpt | 7.24e-04 | 393 | 71 | 7 | IPR000725 | |
| Domain | MHC_I | 2.86e-03 | 21 | 71 | 2 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 2.86e-03 | 21 | 71 | 2 | IPR001039 | |
| Domain | - | 3.73e-03 | 24 | 71 | 2 | 3.30.500.10 | |
| Domain | MHC_I-like_Ag-recog | 3.73e-03 | 24 | 71 | 2 | IPR011161 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 9.58e-06 | 11 | 56 | 3 | M47958 | |
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 16043489 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 9405696 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 12928435 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 20140458 | ||
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 22748890 | ||
| Pubmed | Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. | 1.79e-11 | 4 | 73 | 4 | 9630217 | |
| Pubmed | 1.79e-11 | 4 | 73 | 4 | 21615589 | ||
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 6.99e-11 | 14 | 73 | 5 | 29107716 | |
| Pubmed | Regulation of HCN channel surface expression by a novel C-terminal protein-protein interaction. | 8.91e-11 | 5 | 73 | 4 | 15564593 | |
| Pubmed | 8.91e-11 | 5 | 73 | 4 | 34429357 | ||
| Pubmed | Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. | 6.22e-10 | 7 | 73 | 4 | 19421833 | |
| Pubmed | 3.71e-09 | 10 | 73 | 4 | 16382102 | ||
| Pubmed | Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. | 8.87e-09 | 3 | 73 | 3 | 22652004 | |
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21187420 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 21945247 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 22006928 | ||
| Pubmed | 8.87e-09 | 3 | 73 | 3 | 33181864 | ||
| Pubmed | A family of hyperpolarization-activated mammalian cation channels. | 8.87e-09 | 3 | 73 | 3 | 9634236 | |
| Pubmed | 3.54e-08 | 4 | 73 | 3 | 25042871 | ||
| Pubmed | Autism-associated SHANK3 haploinsufficiency causes Ih channelopathy in human neurons. | 3.54e-08 | 4 | 73 | 3 | 26966193 | |
| Pubmed | Functional coupling of Tmem74 and HCN1 channels regulates anxiety-like behavior in BLA neurons. | 8.84e-08 | 5 | 73 | 3 | 30886335 | |
| Pubmed | 1.77e-07 | 6 | 73 | 3 | 25761792 | ||
| Pubmed | 3.09e-07 | 7 | 73 | 3 | 27956497 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 4.99e-07 | 139 | 73 | 6 | 16985003 | |
| Pubmed | Arrhythmia induced by spatiotemporal overexpression of calreticulin in the heart. | 1.93e-06 | 12 | 73 | 3 | 17482496 | |
| Pubmed | 3.96e-06 | 15 | 73 | 3 | 21147989 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16806719 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19524546 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 30877792 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18033814 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 35024626 | ||
| Pubmed | HCN channelopathy in external globus pallidus neurons in models of Parkinson's disease. | 4.35e-06 | 2 | 73 | 2 | 21076425 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 34175669 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17261842 | ||
| Pubmed | Peripheral N- and C-terminal domains determine deactivation kinetics of HCN channels. | 4.35e-06 | 2 | 73 | 2 | 17548059 | |
| Pubmed | Functional comparison of HCN isoforms expressed in ventricular and HEK 293 cells. | 4.35e-06 | 2 | 73 | 2 | 12194012 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15644313 | ||
| Pubmed | A leucine zipper motif essential for gating of hyperpolarization-activated channels. | 4.35e-06 | 2 | 73 | 2 | 23048023 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15525777 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22948144 | ||
| Pubmed | HCN3 contributes to the ventricular action potential waveform in the murine heart. | 4.35e-06 | 2 | 73 | 2 | 21903939 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 29980633 | ||
| Pubmed | Processing of retinal signals in normal and HCN deficient mice. | 4.35e-06 | 2 | 73 | 2 | 22279546 | |
| Pubmed | Molecular basis of the effect of potassium on heterologously expressed pacemaker (HCN) channels. | 4.35e-06 | 2 | 73 | 2 | 12562911 | |
| Pubmed | Structural determinants of odorant recognition by the human olfactory receptors OR1A1 and OR1A2. | 4.35e-06 | 2 | 73 | 2 | 17601748 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 24638995 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19574228 | ||
| Pubmed | Evolutionary emergence of N-glycosylation as a variable promoter of HCN channel surface expression. | 4.35e-06 | 2 | 73 | 2 | 20130205 | |
| Pubmed | Altered mTOR signaling and enhanced CYFIP2 expression levels in subjects with fragile X syndrome. | 4.35e-06 | 2 | 73 | 2 | 22268788 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17553794 | ||
| Pubmed | Molecular basis for the different activation kinetics of the pacemaker channels HCN2 and HCN4. | 4.35e-06 | 2 | 73 | 2 | 12813043 | |
| Pubmed | Two pacemaker channels from human heart with profoundly different activation kinetics. | 4.35e-06 | 2 | 73 | 2 | 10228147 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12034718 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19171659 | ||
| Pubmed | Intracellular Mg2+ is a voltage-dependent pore blocker of HCN channels. | 4.35e-06 | 2 | 73 | 2 | 18579800 | |
| Pubmed | Mode shifts in the voltage gating of the mouse and human HCN2 and HCN4 channels. | 4.35e-06 | 2 | 73 | 2 | 16777944 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22094222 | ||
| Pubmed | Jak3 is involved in dendritic cell maturation and CCR7-dependent migration. | 4.35e-06 | 2 | 73 | 2 | 19759904 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 21456027 | ||
| Pubmed | Hyperpolarization-activated channels HCN1 and HCN4 mediate responses to sour stimuli. | 4.35e-06 | 2 | 73 | 2 | 11675786 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 17931874 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12890777 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 25704606 | ||
| Pubmed | Case-control pharmacogenetic study of HCN1/HCN2 variants and genetic generalized epilepsies. | 4.35e-06 | 2 | 73 | 2 | 29047147 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22590648 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 12433951 | ||
| Pubmed | HCN3 ion channels: roles in sensory neuronal excitability and pain. | 4.35e-06 | 2 | 73 | 2 | 31290157 | |
| Pubmed | Functional heteromerization of HCN1 and HCN2 pacemaker channels. | 4.35e-06 | 2 | 73 | 2 | 11133998 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 18927079 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 32543742 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 11420311 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19135060 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 15687126 | ||
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 19570998 | ||
| Pubmed | Olfactory receptor 43 reduces hepatic lipid accumulation and adiposity in mice. | 4.35e-06 | 2 | 73 | 2 | 30639733 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | 7.52e-06 | 340 | 73 | 7 | 11875048 | |
| Pubmed | 7.52e-06 | 340 | 73 | 7 | 11802173 | ||
| Pubmed | 7.96e-06 | 343 | 73 | 7 | 32295537 | ||
| Pubmed | 8.42e-06 | 346 | 73 | 7 | 14611657 | ||
| Pubmed | CACNA1C CDK13 ZNF330 PKHD1 CCAR1 MYH15 EMC2 DMWD OR5AR1 PTGFR TOP2B CYFIP2 CFAP46 | 8.60e-06 | 1442 | 73 | 13 | 35575683 | |
| Pubmed | 1.15e-05 | 21 | 73 | 3 | 30270038 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 27421624 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 12856183 | ||
| Pubmed | HCN channels expressed in the inner ear are necessary for normal balance function. | 1.30e-05 | 3 | 73 | 2 | 22090507 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 16079136 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 11206130 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22662315 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 1.30e-05 | 3 | 73 | 2 | 26507659 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19615795 | ||
| Pubmed | Targeted deletion of Kcne2 impairs HCN channel function in mouse thalamocortical circuits. | 1.30e-05 | 3 | 73 | 2 | 22880098 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 23697798 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 23045342 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25212604 | ||
| Pubmed | EP3 activation facilitates bladder excitability via HCN channels on ICCs. | 1.30e-05 | 3 | 73 | 2 | 28131828 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 15292205 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 25771912 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19471099 | ||
| Pubmed | Direct interaction of the mouse cytomegalovirus m152/gp40 immunoevasin with RAE-1 isoforms. | 2.60e-05 | 4 | 73 | 2 | 20166740 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 32184125 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 18317468 | ||
| Interaction | HCN4 interactions | 1.66e-08 | 9 | 70 | 4 | int:HCN4 | |
| Interaction | PEX5L interactions | 1.21e-06 | 54 | 70 | 5 | int:PEX5L | |
| Interaction | KCNE2 interactions | 2.22e-06 | 8 | 70 | 3 | int:KCNE2 | |
| Interaction | HCN3 interactions | 6.49e-06 | 11 | 70 | 3 | int:HCN3 | |
| Interaction | HCN2 interactions | 1.12e-05 | 13 | 70 | 3 | int:HCN2 | |
| Interaction | KEAP1 interactions | 1.94e-05 | 332 | 70 | 8 | int:KEAP1 | |
| GeneFamily | Cyclic nucleotide gated channels | 1.26e-08 | 10 | 52 | 4 | 250 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.67e-06 | 149 | 73 | 5 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | Adult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.22e-06 | 163 | 73 | 5 | 4f5821299b265663c7d0352b28285f56e1988841 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-06 | 164 | 73 | 5 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.44e-06 | 164 | 73 | 5 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.37e-05 | 186 | 73 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.85e-05 | 198 | 73 | 5 | 824461cf44098440ba8bc0df96735423ac65bda1 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.84e-05 | 128 | 73 | 4 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 1.23e-04 | 155 | 73 | 4 | d4ef25965a15eab7679478b9b661e1b4a92f1c59 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 157 | 73 | 4 | 1f21d78a467fe22c5ab75d0917b840c1ac93f32c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_activated|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.39e-04 | 160 | 73 | 4 | bcd90ef96464bd901b87b94c696de70c113bfd03 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-04 | 160 | 73 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_intermediate|World / disease group, cell group and cell class (v2) | 1.39e-04 | 160 | 73 | 4 | 6722934e153b72039c3c4308557d0ef879a30638 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue | 1.52e-04 | 164 | 73 | 4 | 746833f74095c0f25ce76baf1069f1848c231933 | |
| ToppCell | facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 164 | 73 | 4 | 5ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-04 | 164 | 73 | 4 | 3a4ecc632be003d09b765c992804134348d2278b | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_5|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.52e-04 | 164 | 73 | 4 | 4b10b78d4d76023c3c5bcd427757218fdd5465ca | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 166 | 73 | 4 | f4698fd08965936d51695d571bd10fb77330d916 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 1.67e-04 | 168 | 73 | 4 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B-Memory_B_cells|GI_small-bowel / Manually curated celltypes from each tissue | 1.67e-04 | 168 | 73 | 4 | 8e025bb0541746e232b77ac0e31412ae71420c47 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_B|GI_small-bowel / Manually curated celltypes from each tissue | 1.67e-04 | 168 | 73 | 4 | 5535c1b8b7fde7b59a1bc0580cebdfa963aa1c39 | |
| ToppCell | URO-Lymphocyte-B-B_intermediate|URO / Disease, Lineage and Cell Type | 1.75e-04 | 170 | 73 | 4 | e11d1510518cedabeece96d4adbb90999e6326fa | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-04 | 171 | 73 | 4 | 8bed33f61f7d12a1ac4fba33f730d839f5ee7bef | |
| ToppCell | COVID-19-kidney-Bcells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.79e-04 | 171 | 73 | 4 | 8e8fb79968b1a5c34d1d9cad7f9155fabfdb7cc7 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Lymphocytic-B_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | a693772987f1baee533dd0bd285a3c7b5619a73b | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 173 | 73 | 4 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.87e-04 | 173 | 73 | 4 | 9082ad77b44f65b72094df6e502cce81b62fe81a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 175 | 73 | 4 | 738b3d476ac494e2e79b70b3b83bc1b7ae8396bd | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 175 | 73 | 4 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 2.04e-04 | 177 | 73 | 4 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|World / disease group, cell group and cell class (v2) | 2.04e-04 | 177 | 73 | 4 | 057871e211c6508b2a679d391f3cf0ac7ccfc628 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | 5a4f97d19265577cfdb3e53f9dc3a9a02cfcffa9 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-04 | 179 | 73 | 4 | c09c3eed43d1aa3b7aa8f3021e6f2737840cde16 | |
| ToppCell | droplet-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 179 | 73 | 4 | 006f2b6887b0f1f26e58bb11c919468b62bf4d62 | |
| ToppCell | IPF-Lymphoid-B|World / Disease state, Lineage and Cell class | 2.17e-04 | 180 | 73 | 4 | 30f9398c9b784f49470847a025bac90687e997a1 | |
| ToppCell | severe-CD8+_T_naive|World / disease stage, cell group and cell class | 2.22e-04 | 181 | 73 | 4 | 69eeeb7f326e230b07495d557f708fbe3312ac0a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 181 | 73 | 4 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | Control-Lymphoid-B|World / Disease state, Lineage and Cell class | 2.22e-04 | 181 | 73 | 4 | 9124f1a610cfc3355ad87921cd3eb5346956475d | |
| ToppCell | nucseq-Immune-Lymphocytic_B-Lymphocytic_B-B|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.22e-04 | 181 | 73 | 4 | 8d8cc4dae2c8bd5f4b1c159f2a52edc4c9449c86 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 182 | 73 | 4 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | IPF-Lymphoid-B|IPF / Disease state, Lineage and Cell class | 2.32e-04 | 183 | 73 | 4 | e37d2c015c34471a8a54a0299e94b0371e1ada5a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.32e-04 | 183 | 73 | 4 | dd15e1463a0d57d14800de0df0645c81c56926ae | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_B-B_plasma|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.32e-04 | 183 | 73 | 4 | 8ace19c38b89556d2504258a63aa5a2b14f5cd36 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.32e-04 | 183 | 73 | 4 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | Control-Lymphoid-B|Control / Disease state, Lineage and Cell class | 2.36e-04 | 184 | 73 | 4 | de0294f879268bfd68e91adcc2adba211d221b7a | |
| ToppCell | COVID-19-lung-B_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-04 | 185 | 73 | 4 | e8f1ad580f19705b5ca1d7d8867b2125f4891684 | |
| ToppCell | Control-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 2.46e-04 | 186 | 73 | 4 | e9e58c5871b4966cd3586b611703e21af8df6360 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 187 | 73 | 4 | 16e55d802fc4e71878305e61ad03806aabd59537 | |
| ToppCell | Control-Myeloid-DC_Mature|Control / Disease state, Lineage and Cell class | 2.51e-04 | 187 | 73 | 4 | 049780ca2a3e6adcd89dc2cf3095b5ad068b244a | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-NK_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.51e-04 | 187 | 73 | 4 | 3301e0fca8c436d136c71f1a8fd59b3bb11bdd83 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-04 | 187 | 73 | 4 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Control-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 2.51e-04 | 187 | 73 | 4 | 51bfc450e78284796b02317e91830357850b5437 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.51e-04 | 187 | 73 | 4 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.57e-04 | 188 | 73 | 4 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 188 | 73 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 189 | 73 | 4 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.62e-04 | 189 | 73 | 4 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 190 | 73 | 4 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 190 | 73 | 4 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-04 | 190 | 73 | 4 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.67e-04 | 190 | 73 | 4 | a7498fe55b7810c482291db782dc5282675d246a | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.67e-04 | 190 | 73 | 4 | 95b9334573eefb132daaa9371377ad60232006ae | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 191 | 73 | 4 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 191 | 73 | 4 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | (11)_FOXN4+-(0)_Reference|(11)_FOXN4+ / shred by cell type by condition | 2.78e-04 | 192 | 73 | 4 | ef06f96b934dd05b40025f8215b6d919d3a17045 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 192 | 73 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | mild_COVID-19-B_memory|World / disease group, cell group and cell class (v2) | 2.83e-04 | 193 | 73 | 4 | 69b70c838328fdc7dbb6b5449fe2811a5389a839 | |
| ToppCell | mild_COVID-19-B_memory|mild_COVID-19 / disease group, cell group and cell class (v2) | 2.83e-04 | 193 | 73 | 4 | 7e6fe70928a50b0a8f12220e572c07c5670d092e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | distal-Hematologic-B_cell-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.83e-04 | 193 | 73 | 4 | 202dc5ec2437602c15658074728c5f5aeeab0466 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-04 | 193 | 73 | 4 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | severe_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 2.89e-04 | 194 | 73 | 4 | cb346cb186fe80a8f490ae90b2539b3543ba0ca9 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 2.89e-04 | 194 | 73 | 4 | d70b9039fd2fef3e4be086513b94fb7e9bc1f670 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.89e-04 | 194 | 73 | 4 | 40c7f9bd69a8e843b81972e25a67f591021415dd | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 2.89e-04 | 194 | 73 | 4 | 5151546812678ae85cb22224084d27b29e3c4724 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_mem-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.95e-04 | 195 | 73 | 4 | 51e6cfecd66a874673d0b79a295489a358bddfd5 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.95e-04 | 195 | 73 | 4 | 517af3e6784f02c382df6f5691945eefaa9ec4ae | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 195 | 73 | 4 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.01e-04 | 196 | 73 | 4 | c225c8eb2fe9a10f0cf574c7d8b6206887aac2df | |
| ToppCell | distal-1-Hematologic-B_cell|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.01e-04 | 196 | 73 | 4 | f442060d743b3ad2f9e5e343d4696411eef7f498 | |
| ToppCell | (05)_Secretory-(0)_Reference|(05)_Secretory / shred by cell type by condition | 3.01e-04 | 196 | 73 | 4 | 7cb79cf122852c971f2d6e8d1e2b26eade891e83 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.01e-04 | 196 | 73 | 4 | 3f065139f76ed048875cd6c03aa02300db2b6574 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-04 | 197 | 73 | 4 | ccabb976b5d4800e87e550640454a893fdb3b1b6 | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 3.06e-04 | 197 | 73 | 4 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | severe_COVID-19-B_intermediate|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.06e-04 | 197 | 73 | 4 | 3ba64850b344cb24a4d20d64392a0b2752950d40 | |
| ToppCell | BAL-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.06e-04 | 197 | 73 | 4 | 513ada82bbbb6a624d89edaa54f8c4a303dfb5e7 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-04 | 197 | 73 | 4 | 6f83fc049f38f3de6bc5180ad4b51ceb4d5dcdb6 | |
| ToppCell | Control-Myeloid-cDC|Control / Disease group,lineage and cell class （2021.01.30） | 3.06e-04 | 197 | 73 | 4 | aef933107da42a763b35041c90950db07707c0cb | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.06e-04 | 197 | 73 | 4 | 15e683f4a610aad3e06723747c8e56ca25f57414 | |
| ToppCell | mild_COVID-19-B_intermediate|World / disease group, cell group and cell class (v2) | 3.06e-04 | 197 | 73 | 4 | e909b898b7458071f176b6c04356ea3540589153 | |
| ToppCell | BAL-Control-Myeloid-cDC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.06e-04 | 197 | 73 | 4 | 6ac50c02899531a25885749d5305da788dfa9dbc | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-04 | 198 | 73 | 4 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.12e-04 | 198 | 73 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-B_intermediate|URO / Disease, condition lineage and cell class | 3.12e-04 | 198 | 73 | 4 | aea2defa941adc8eeee601885cd13817ba108e57 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.12e-04 | 198 | 73 | 4 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.12e-04 | 198 | 73 | 4 | 863765ccc0205dc28864dae85af339c283194c96 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-04 | 200 | 73 | 4 | 2f481e2fd248c02a5aa2e0248c16808df142fed2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 9b614b8b949aa7d3ddbe613db6e08adaf04535a7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Neuron-Neuron-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.24e-04 | 200 | 73 | 4 | bd4b9f6b37f4a3c960c4149cf0cfd2caf3327d2d | |
| Drug | HCNs | 4.53e-07 | 20 | 73 | 4 | CID006857665 | |
| Drug | loperamide | 1.10e-06 | 105 | 73 | 6 | CID000003954 | |
| Drug | lercanidipine | 1.79e-06 | 63 | 73 | 5 | CID000065866 | |
| Drug | CNS 1145 | 3.71e-06 | 33 | 73 | 4 | CID000190902 | |
| Drug | IHC-64 | 3.71e-06 | 33 | 73 | 4 | CID000162753 | |
| Drug | ethosuximide | 4.00e-06 | 74 | 73 | 5 | CID000003291 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 6.42e-06 | 308 | 73 | 8 | CID000001915 | |
| Drug | capsazepine | 7.47e-06 | 84 | 73 | 5 | CID002733484 | |
| Drug | menthol | 8.88e-06 | 87 | 73 | 5 | CID000001254 | |
| Drug | zatebradine | 2.08e-05 | 17 | 73 | 3 | CID000065637 | |
| Drug | AC1L1GTQ | 2.72e-05 | 54 | 73 | 4 | CID000003836 | |
| Drug | zatebradine | 3.04e-05 | 3 | 73 | 2 | ctd:C043636 | |
| Drug | Cinildipine | 3.15e-05 | 56 | 73 | 4 | CID000002752 | |
| Drug | CID5255110 | 3.38e-05 | 57 | 73 | 4 | CID005255110 | |
| Drug | Pilocarpine | 3.60e-05 | 285 | 73 | 7 | ctd:D010862 | |
| Drug | AC1NBU2S | 3.74e-05 | 117 | 73 | 5 | CID004473765 | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; MCF7; HT_HG-U133A | 3.97e-05 | 196 | 73 | 6 | 2851_UP | |
| Drug | nilvadipine | 4.14e-05 | 60 | 73 | 4 | CID000004494 | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; HL60; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 3067_UP | |
| Drug | Dicumarol [66-76-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.21e-05 | 198 | 73 | 6 | 3941_UP | |
| Drug | IAA-94 | 4.42e-05 | 61 | 73 | 4 | CID000003667 | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 4.45e-05 | 200 | 73 | 6 | 3182_UP | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.45e-05 | 200 | 73 | 6 | 6838_UP | |
| Drug | genistein | SCRT2 JAK3 CACNA1B CACNA1C TRPA1 MTOR HCN1 MAZ ITGB3 KAT14 STAR TOP2B RYR1 | 4.94e-05 | 1117 | 73 | 13 | CID005280961 |
| Drug | gallopamil | 6.40e-05 | 67 | 73 | 4 | CID000001234 | |
| Drug | AC1L2AC7 | 7.18e-05 | 69 | 73 | 4 | CID000068733 | |
| Drug | CAS 298-57-7 | 8.95e-05 | 73 | 73 | 4 | CID000002761 | |
| Drug | Dantrolene-13C3 | 1.04e-04 | 145 | 73 | 5 | CID000002951 | |
| Drug | NSC683246 | 1.06e-04 | 234 | 73 | 6 | CID000005097 | |
| Drug | nisoldipine | 1.16e-04 | 78 | 73 | 4 | CID000004499 | |
| Drug | 6-carboxyfluorescein diacetate | 1.21e-04 | 30 | 73 | 3 | CID000151095 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.22e-04 | 79 | 73 | 4 | CID005287890 | |
| Disease | level of UL16-binding protein 6 in blood serum | 5.55e-06 | 2 | 70 | 2 | OBA_2043185 | |
| Disease | meningitis (biomarker_via_orthology) | 5.55e-06 | 2 | 70 | 2 | DOID:9471 (biomarker_via_orthology) | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 1.66e-05 | 3 | 70 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Endocrine System Diseases | 1.66e-05 | 3 | 70 | 2 | C0014130 | |
| Disease | hexanoylglycine measurement | 1.16e-04 | 7 | 70 | 2 | EFO_0800233 | |
| Disease | Brugada syndrome | 1.54e-04 | 8 | 70 | 2 | cv:C1142166 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 1.54e-04 | 8 | 70 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | body weight | NPC1 CACNA1B CACNA1C COPG1 MTOR ZNF280C TSPAN8 CD79B GNAS HUWE1 EFR3A | 1.77e-04 | 1261 | 70 | 11 | EFO_0004338 |
| Disease | Tremor, Rubral | 6.52e-04 | 16 | 70 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 6.52e-04 | 16 | 70 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 6.52e-04 | 16 | 70 | 2 | C0278161 | |
| Disease | Abnormal coordination | 6.52e-04 | 16 | 70 | 2 | C0520966 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 6.52e-04 | 16 | 70 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Ataxia, Truncal | 6.52e-04 | 16 | 70 | 2 | C0427190 | |
| Disease | Ataxia, Sensory | 6.52e-04 | 16 | 70 | 2 | C0240991 | |
| Disease | body surface area | 8.25e-04 | 643 | 70 | 7 | EFO_0022196 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 9.24e-04 | 19 | 70 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Anhedonia | 1.48e-03 | 24 | 70 | 2 | C0178417 | |
| Disease | Brugada Syndrome (disorder) | 1.48e-03 | 24 | 70 | 2 | C1142166 | |
| Disease | Ataxia | 1.61e-03 | 25 | 70 | 2 | C0004134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHMCEYLLKAGESQM | 191 | Q8TDY4 | |
| LMASPSMEDLYHKSC | 451 | Q8IX12 | |
| YKMSFFSGMLLLLCI | 136 | P32248 | |
| ELFASMVHILMGSCY | 541 | Q8IY22 | |
| MACAHRALEMGIKYL | 956 | Q8IYW2 | |
| MTLQELVHKAASCYM | 1 | Q4L235 | |
| EGHRMLAMSYTCQAK | 431 | Q9ULJ7 | |
| FNMTTNHSFMCLIKY | 206 | P33681 | |
| CGRISYNDMFEMLKH | 1741 | Q00975 | |
| FHFDSMLLRGLMKSY | 311 | Q09019 | |
| KRGFTVKMHCYMNSA | 56 | P40259 | |
| SFMRQLMEGLDYCHK | 816 | Q14004 | |
| MFHRCGIMALVAAYL | 591 | Q14156 | |
| ACQADRHSLMAKYIM | 226 | P52333 | |
| PFCKFVSAMLHIHMY | 86 | Q7Z602 | |
| MSMGLLHFYKSRSCS | 131 | Q2M2E3 | |
| KLSCSDVHFNVKMMY | 186 | Q9Y585 | |
| QGMLSMAGLHYSTCL | 736 | Q6ZMT4 | |
| KYMSHLASCGMGLLL | 196 | Q76MJ5 | |
| HVKMMLSGVCLFAVF | 151 | P43088 | |
| ATFMIYHLIQTCMGK | 716 | Q9H8E8 | |
| VCGKMLSSAYISDHM | 396 | P56270 | |
| MAMASFYHARCLQLG | 296 | Q9P2M1 | |
| KYLMGEHGQSCAKML | 336 | O15297 | |
| LCKHMTLDSFDAMFR | 836 | Q96F07 | |
| ALFKAMSHMLCIGYG | 301 | Q9P1Z3 | |
| LTAAHAYIMMFVHTC | 896 | Q7Z6Z7 | |
| SYALFKAMSHMLCIG | 466 | Q9Y3Q4 | |
| AFAHTECLILVMMSY | 106 | Q96R48 | |
| MFLYISLALGHMKSC | 631 | O15118 | |
| SYALFKAMSHMLCIG | 346 | O60741 | |
| KAMSHMLCIGYGAQA | 351 | O60741 | |
| GLELFMGKMHKTCYN | 286 | Q13936 | |
| MVAMLHTAANFGLYC | 401 | Q7Z601 | |
| SHNKACTMLFMILYF | 281 | Q9NPG1 | |
| MKTTCLPMFGYKHVL | 206 | P05106 | |
| HGLKSPFAYCMMIRV | 221 | Q9Y678 | |
| MRALFGLYMSASHIA | 226 | Q15006 | |
| LKDLMRASYPCMSLH | 636 | Q7L014 | |
| LYMAYADIMAKSCHL | 3721 | P21817 | |
| FALFKAMSHMLCIGY | 416 | Q9UL51 | |
| HPLHYSSMMSKVFCS | 146 | Q8NGR1 | |
| KLSCSDIHFHVKMMY | 186 | Q9P1Q5 | |
| AYGAMVSCHMLSELE | 1586 | P42345 | |
| IFAIAECHMLAAMAY | 106 | P0DMU2 | |
| SGSKIRAFMMCLHAY | 491 | Q8WU17 | |
| KYGAMALKSRACHEM | 276 | Q9NXH9 | |
| CGKAYVSMPALAMHL | 191 | Q9NQ03 | |
| MVLFDHMGCLKKYET | 1021 | Q02880 | |
| YSMFQCKAHLVMRLI | 446 | Q6P1X5 | |
| CYKLTGAIMHFGNMK | 361 | Q9Y2K3 | |
| EKMGYMCTHRLLLLG | 676 | Q5JWF2 | |
| YVSLFKHQMLCDMAR | 96 | Q9BSH3 | |
| DMSHVKAACIMCAYL | 306 | Q9NY91 | |
| KAMLFMCSGSIIHNL | 336 | P03915 | |
| YVAICKPLHYMAIMS | 121 | A6NDL8 | |
| LQHCLYSMSEKMLGS | 2166 | P08F94 | |
| HYSTFMSKQVCLALM | 131 | Q8NGP9 | |
| AMIKMVFIAQLHYCG | 161 | Q8NGX8 | |
| LRACAKYHMEMNSKS | 166 | Q9BXB5 | |
| VLCLLYAMSHNKGMD | 501 | Q2KHT3 | |
| GLLMFAVTHMFYASA | 96 | Q8N2M4 | |
| FRAHMMNLGSYCLGL | 716 | O75762 | |
| MDSYTMRFCGHLAAV | 536 | Q9ULX5 | |
| FKLCAGSSYRHMRNM | 6 | P49675 | |
| KDVAMSFHYISMGDC | 176 | Q5VY80 | |
| KYQAAMSHLLEMCVS | 311 | Q8N4Q0 | |
| FARYLHSNMMAATLC | 161 | Q8IYT8 | |
| MMKSSDCVIKHAGVY | 76 | Q9Y3S2 | |
| FCLKVSKMATPYMNH | 446 | Q8ND82 | |
| KVVAMSFHYFSMGDC | 176 | Q9BZM5 | |
| MAGVSACIKYSMFTF | 1 | P19075 | |
| KAIYHMLNMCSFDVT | 306 | Q9Y487 | |
| SAALCLAYLMKYHAM | 111 | Q8NEJ0 | |
| ALLANMAAMFAIYHG | 386 | P23378 | |
| MQCSELYHMAKAFAL | 446 | Q96CT2 |